Titlebook: Biology and Management of Multiple Myeloma; James R. Berenson Book 2004 Springer Science+Business Media New York 2004 Staging.anemia.bone

只看該作者 · 發(fā)表于 2025-3-21 19:41:45

書目名稱Biology and Management of Multiple Myeloma影響因子(影響力)

書目名稱Biology and Management of Multiple Myeloma影響因子(影響力)學(xué)科排名

書目名稱Biology and Management of Multiple Myeloma網(wǎng)絡(luò)公開度

書目名稱Biology and Management of Multiple Myeloma網(wǎng)絡(luò)公開度學(xué)科排名

書目名稱Biology and Management of Multiple Myeloma被引頻次

書目名稱Biology and Management of Multiple Myeloma被引頻次學(xué)科排名

書目名稱Biology and Management of Multiple Myeloma年度引用

書目名稱Biology and Management of Multiple Myeloma年度引用學(xué)科排名

書目名稱Biology and Management of Multiple Myeloma讀者反饋

書目名稱Biology and Management of Multiple Myeloma讀者反饋學(xué)科排名

只看該作者 · 發(fā)表于 2025-3-21 22:49:09

只看該作者 · 發(fā)表于 2025-3-22 00:31:53

Dose-Intensive Therapy With Autologous Stem Cell Transplantation for Patients With Multiple Myelomah MM .. Barlogie and colleagues introduced the concept of high-dose chemotherapy followed by autologous stem cell transplantation in the 1980s . and rapidly several large trials were performed in patients with MM ..

只看該作者 · 發(fā)表于 2025-3-22 06:12:27

只看該作者 · 發(fā)表于 2025-3-22 12:38:57

New Therapeutic Approaches to Myeloma,lan-prednisone (MP) combination therapy, a number of cytotoxic drug combinations have been investigated. A popular example is the M2 protocol, consisting of vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) ..

只看該作者 · 發(fā)表于 2025-3-22 16:16:42

Sprechweisen in der (Konflikt)Moderationd that a less mature B lymphocyte or even a primordial stem cell might be clonal .. In this proposed model, these precursor cells could then sustain the plasma cell pool through differentiation in a manner akin to the process that occurs in chronic myelogenous leukemia. Recent advances in molecular

只看該作者 · 發(fā)表于 2025-3-22 20:20:50

Gesellschaftspolitik und Staatst?tigkeitdirect measures of tumor bulk and activity such as hemoglobin, calcium, serum and urine M-protein levels, number of bone lesions, and creatinine levels. Combining a series of inaccurate measures of tumor burden has proved to have limitations. In particular, quantification of bone lesions is unreliab

只看該作者 · 發(fā)表于 2025-3-23 00:36:28

只看該作者 · 發(fā)表于 2025-3-23 02:17:34

只看該作者 · 發(fā)表于 2025-3-23 07:15:28

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 06:29
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved